Acute Effect of Photobiomodulation Therapy on Muscle Performance in Female Futsal Players

NCT06562322 | Completed

• 1 other identifier: Photobiomodulation and futsal
• Study Type: interventional
• Target: 15
• Locations: 1 country
• Sites: 1

Brief Summary

Photobiomodulation therapy (PBMT) has recently been indicated as a potential therapeutic strategy in diverse health and sports contexts. However, its efficacy on muscle performance in female futsal players remains unknown. The purpose of this study was to investigate the dose-response effect of PBMT on muscle performance in female futsal players.

Conditions

Muscle Performance; Photobiomodulation Therapy

Keywords

Physical test; Photobiomodulation therapy; Futsal; Light-emitting diodes; Muscle power; Muscle strength

Outcome Measures

Primary Outcomes (5)

• Repetitions-to-failure

  The repetitions-to-failure test in the 45º leg press exercise consists of 3 sets at 70% of 1RM, with a 60-s rest interval between each set. Participants will perform as many repetitions as possible until momentary failure (i.e., when the participant is unable to complete the concentric portion of their current repetition across the full range of motion despite using maximal effort), and the maximum number of repetitions in each set will be recorded.

  10 minutes

• Fatigue index (FI)

  The fatigue index (FI) will be determined by the equation: \[(REPS3 - REPS1)/REPS1\]\*100, where: REPS3 = number of repetitions in set 3, multiplied by the load lifted, and REPS1 = number of repetitions in set 1, multiplied by the load lifted. The higher the FI value (%), the higher the level of muscle fatigue.

  10 minutes

• Rating of perceive exterion (RPE)

  Rating of perceived exertion (RPE) will be recorded immediately after completion of each set using the OMNI-RES scale. The participants will be instructed to report the perceived exertion value by indicating a number on the OMNI-RES scale (0 for ''no effort'' and 10 for ''maximal effort'') that best represented their momentary exertion.

  10 minutes

• Countermovement vertical jump (CMJ)

  The CMJ test will be performed on a force platform (BIOMEC400-412, EMG System to Brazil Ltda, São Paulo, Brazil) to assess the flight time. Participants will perform three CMJs, interspersed with 1 min of rest, and the highest flight time will be used as an indicator of muscle power. The test will began with the participant standing, knees extended, and hands fixed on the iliac crest region (hips). The participant then will flexed their legs at an angle of approximately 90º and then quickly extended their legs to maximize the height of the jump. Hands will be kepted on hips throughout the jump.

  10 minutes

• Maximum voluntary isometric contraction (MVIC)

  The MVIC test for the leg extension exercise (bilateral) will be performed using an isometric dynamometer (CEFISE Biotechnology, São Carlos, Brazil). Briefly, participants will perform three MVICs at 120º of knee flexion (180º = full extension) lasting 5 s, interspersed with 5 s of rest. Participants will be instructed and verbally encouraged to exert maximum force during all attempts. The highest value obtained for peak and mean torque of the three MVICs will be used for the analysis.

  10 minutes

Study Arms (4)

placebo PBMT

PLACEBO COMPARATOR

Participants will be received placebo PBMT immediately before physical tests.

Device: Placebo

300 J PBMT

ACTIVE COMPARATOR

Participants will be received PBMT at 300 J immediately before physical tests.

Device: 300 J

600 J PBMT

ACTIVE COMPARATOR

Participants will be received PBMT at 600 J immediately before physical tests.

Device: 600 J

1260 J PBMT

ACTIVE COMPARATOR

Participants will be received PBMT at 1260 J immediately before physical tests.

Device: 1260 J

Interventions

Placebo DEVICE

Participants will be received placebo PBMT on the quadriceps muscle of both legs, immediately before physical tests, using a device containing 200 LEDs (100 red and 100 infrared)

placebo PBMT

300 J DEVICE

Participants will be received PBMT at 300 J on the quadriceps muscle of both legs, immediately before physical tests, using a device containing 200 LEDs (100 red and 100 infrared)

300 J PBMT

600 J DEVICE

Participants will be received PBMT at 600 J on the quadriceps muscle of both legs, immediately before physical tests, using a device containing 200 LEDs (100 red and 100 infrared)

600 J PBMT

1260 J DEVICE

Participants will be received PBMT at 1260 J on the quadriceps muscle of both legs, immediately before physical tests, using a device containing 200 LEDs (100 red and 100 infrared)

1260 J PBMT

Eligibility Criteria

• Age: 18 Years - 35 Years
• Sex: female
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64)

You may qualify if:

• Age between 18 and 35 years
• Playing futsal regularly for more than 1 year.

You may not qualify if:

• Use of any ergogenic or anabolic supplement within 6 months prior to the start of the study,
• Take any medication that may affect the ability to perform the physical tests,
• Have any physical limitation (e.g. joint or muscle injury) that may affect the ability to perform the physical test,
• Be engaged in a restricted diet program (e.g. weight loss diet),
• Have any skin sensitivity or diseases (e.g. erysipelas, eczema, dermatitis, psoriasis and urticaria) in the irradiated area that may be aggravated by PBMT.

Sponsors & Collaborators

• Universidade Norte do Paraná: lead

Study Sites (1)

Universidade Norte do Paraná

Londrina, Paraná, 86.041-140, Brazil

Location

Related Publications (3)

• Steele J, Fisher J, Giessing J, Gentil P. Clarity in reporting terminology and definitions of set endpoints in resistance training. Muscle Nerve. 2017 Sep;56(3):368-374. doi: 10.1002/mus.25557. Epub 2017 Apr 1.

  PMID: 28044366 BACKGROUND

• Robertson RJ, Goss FL, Rutkowski J, Lenz B, Dixon C, Timmer J, Frazee K, Dube J, Andreacci J. Concurrent validation of the OMNI perceived exertion scale for resistance exercise. Med Sci Sports Exerc. 2003 Feb;35(2):333-41. doi: 10.1249/01.MSS.0000048831.15016.2A.

  PMID: 12569225 BACKGROUND

• Luque MZ, Aguiar AF, da Silva-Araujo AK, Zaninelli TH, Heintz OK, Saraiva-Santos T, Bertozzi MM, Souza NA, Junior EO, Verri WA Jr, Borghi SM. Evaluation of a preemptive intervention regimen with hesperidin methyl chalcone in delayed-onset muscle soreness in young adults: a randomized, double-blinded, and placebo-controlled trial study. Eur J Appl Physiol. 2023 Sep;123(9):1949-1964. doi: 10.1007/s00421-023-05207-2. Epub 2023 Apr 29.

  PMID: 37119360 BACKGROUND

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: DOUBLE
• Who Masked: PARTICIPANT, OUTCOMES ASSESSOR
• Purpose: BASIC SCIENCE
• Intervention Model: CROSSOVER
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal investigator

Model Details: Crossover

Study Record Dates

• First Submitted: August 16, 2024
• First Posted: August 20, 2024
• Study Start: February 15, 2024
• Primary Completion: March 15, 2024
• Study Completion: March 18, 2024
• Last Updated: January 9, 2026

Record last verified: 2024-08

Data Sharing

• IPD Sharing: Will not share

Locations

BR (1)